-transparent.png){kind=logo}
There are few critical studies on plasma testosterone (T) and 17 beta-estradiol (E2) levels in men with hCG-producing tumors, and the results are contradictory. Plasma E2 levels are most often elevated, whereas plasma T values are high or in the normal range. We studied the plasma levels of such steroids and of delta 4 and delta 5 T precursors in adult men with intact hCG-producing tumors to evaluate the relationship between hCG and steroid hormone levels or steroidogenic enzyme activities. Ten adult men with hCG-producing tumors and 25 normal adult men were investigated. Seven men with testicular tumors were studied before and after hemicastration. The 2 patients with extratesticular tumors were investigated before and during chemotherapy. The remaining patient was studied every 2 months for 1 yr during the spontaneous course of the disease. Plasma progesterone (P), 17 alpha-hydroxyprogesterone (17-OHP), androstenedione (A), 17-hydroxy-delta 5-pregnenolone (17-OH delta 5-P), dehydroepiandrosterone (DHEA), T, E2, and hCG were measured, and ratios of steroid levels were also calculated. In patients with increased hCG values (i.e. > 5 IU/L), the mean plasma P, 17-OHP, A, 17-OH delta 5-P, DHEA, T, and E2 levels were higher (P < 0.01 at least) than those in patients whose hCG values were normalized or in controls. The patterns of these steroids were very different according to plasma hCG levels. Indeed, for hCG levels between more than 5 and 3.5 x 10(3) IU/L, positive correlations (P < 0.05 at least) were found between hCG levels and delta 4 T precursor, delta 5 T precursor, T, or E2 values. Conversely, for hCG values greater than 3.5 x 10(3) IU/L, hCG levels were negatively correlated (P < 0.05 at least) to all steroid values. Furthermore, in patients with increased hCG levels, the mean plasma P to 17-OHP ratio, 17-OHP to A ratio, A to T ratio, 17-OHP to T ratio, and 17-OH delta 5-P to DHEA ratio were similar to those in patients with normalized hCG values or in controls. In contrast, in patients with increased hCG levels, the mean plasma T to E2 ratio value was lower (P < 0.001) than that in patients with normalized hCG levels or in controls.(ABSTRACT TRUNCATED AT 400 WORDS)
M Rieu, and
Y Reznik, and
J M Vannetzel, and
J Mahoudeau, and
J L Berrod, and
J M Kuhn
January 1974,
Surgical forum,
M Rieu, and
Y Reznik, and
J M Vannetzel, and
J Mahoudeau, and
J L Berrod, and
J M Kuhn
July 1979,
The Journal of biological chemistry,
M Rieu, and
Y Reznik, and
J M Vannetzel, and
J Mahoudeau, and
J L Berrod, and
J M Kuhn
January 1988,
Archives of andrology,
M Rieu, and
Y Reznik, and
J M Vannetzel, and
J Mahoudeau, and
J L Berrod, and
J M Kuhn
December 1971,
The Journal of clinical endocrinology and metabolism,
M Rieu, and
Y Reznik, and
J M Vannetzel, and
J Mahoudeau, and
J L Berrod, and
J M Kuhn
September 1976,
Neurologia medico-chirurgica,
M Rieu, and
Y Reznik, and
J M Vannetzel, and
J Mahoudeau, and
J L Berrod, and
J M Kuhn
July 2014,
Urologic oncology,
M Rieu, and
Y Reznik, and
J M Vannetzel, and
J Mahoudeau, and
J L Berrod, and
J M Kuhn
March 1987,
The Journal of urology,
M Rieu, and
Y Reznik, and
J M Vannetzel, and
J Mahoudeau, and
J L Berrod, and
J M Kuhn
January 1984,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
M Rieu, and
Y Reznik, and
J M Vannetzel, and
J Mahoudeau, and
J L Berrod, and
J M Kuhn
September 1997,
Pathology international,
M Rieu, and
Y Reznik, and
J M Vannetzel, and
J Mahoudeau, and
J L Berrod, and
J M Kuhn
October 1966,
Horumon to rinsho. Clinical endocrinology,
